For the Inventor, By the Inventor

Enter assignee name

Bothell, WA, United States of America

Cocrystal Pharma, Inc.

USPTO Granted Patents = 16

EPO Patents = 7

Forward Citations = 47

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Irina C Jacobson (9 out of 25 patents)

Steven J Coats (7 out of 27 patents)

Raymond F Schinazi (6 out of 124 patents)

4. Sam S K Lee (5 out of 6 patents)

5. Franck Amblard (5 out of 15 patents)

6. Michael David Feese (4 out of 6 patents)

7. Sam S Lee (4 out of 4 patents)

8. Hongwang Zhang (4 out of 7 patents)

9. Longhu Zhou (4 out of 8 patents)

10. Richard Anthony Whitaker (3 out of 8 patents)

11. Tamara Rosario McBrayer (3 out of 5 patents)

12. Junxing Shi (3 out of 23 patents)

13. Biing Yuan Lin (3 out of 3 patents)

14. Wang Shen (1 out of 44 patents)

15. Xiaoling Zheng (1 out of 10 patents)

16 patents: Sort by Forward Citations

1. 12357631 - Pyrrolo[2,3-B]pyridin derivatives as inhibitors of influenza virus replication (2025-07-15),

2. 12233066 - Combinations of inhibitors of influenza virus replication (2025-02-25),

3. 12156876 - Formulations of influenza therapeutics (2024-12-03),

4. 12037333 - Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication (2024-07-16),

5. 11752166 - Combination therapy for treatment of HCV (2023-09-12),

6. 11014941 - Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication (2021-05-25),

7. 10947210 - Inhibitors of Hepatitis C virus polymerase (2021-03-16),

8. 10464914 - Inhibitors of hepatitis C virus polymerase (2019-11-05),

9. 10426762 - Inhibitors of hepatitis C virus polymerase (2019-10-01),

10. 10011629 - Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer (2018-07-03),

11. 9932326 - Potent and selective inhibitors of hepatitis C virus (2018-04-03),

12. 9926295 - Potent and selective inhibitors of hepatitis C virus (2018-03-27),

13. 9809616 - Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancer (2017-11-07),

14. 9181227 - Potent and selective inhibitors of hepatitis C virus (2015-11-10),

15. 9173893 - Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections (2015-11-03),

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company dedicated to discovering and developing novel antiviral therapeutics for viral diseases. The company utilizes its proprietary structure-based drug discovery technology platform to create first-in-class antiviral compounds. Cocrystal Pharma focuses on developing treatments for hepatitis, influenza, and respiratory syncytial virus (RSV) infections. With a mission to improve patient outcomes, the company is committed to advancing innovative therapies to address critical unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

16 Patents

#26 in Bothell, WA

#404 in Washington

#19,327 in US

#36,704 in the World

Bothell, WA, United States of America

Cocrystal Pharma, Inc.

Forward Citations = 47

22 inventors:

Irina C Jacobson (9 out of 25 patents)

Steven J Coats (7 out of 27 patents)

Raymond F Schinazi (6 out of 124 patents)

4. Sam S K Lee (5 out of 6 patents)

5. Franck Amblard (5 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…